|
Volumn 357, Issue 9274, 2001, Pages 2115-2121
|
Pathways for self-tolerance and the treatment of autoimmune diseases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGEN;
B LYMPHOCYTE RECEPTOR;
CD40 ANTIGEN;
CORTICOSTEROID;
CYCLOSPORIN A;
FAS ANTIGEN;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
IMMUNOMODULATING AGENT;
INTERLEUKIN 2;
INTERLEUKIN 4;
LIGAND;
LIPOPOLYSACCHARIDE;
LYMPHOCYTE ANTIGEN RECEPTOR;
PROTEIN;
PROTEIN B7;
PROTEIN TYROSINE KINASE;
T LYMPHOCYTE RECEPTOR;
TACROLIMUS;
TOLL LIKE RECEPTOR;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ANTIGEN BINDING;
ARTICLE;
AUTOIMMUNE DISEASE;
CELL DEATH;
CLONAL ANERGY;
COMPLEMENT SYSTEM;
HUMAN;
IMMUNE RESPONSE;
IMMUNOGENICITY;
IMMUNOLOGICAL TOLERANCE;
MONOGENIC DISORDER;
PATHOGENESIS;
PRIORITY JOURNAL;
T LYMPHOCYTE;
|
EID: 0035973343
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(00)05185-0 Document Type: Note |
Times cited : (72)
|
References (52)
|